Obesity
Showing NaN - NaN of 47
Obesity Trial in Atlanta (PATH Intervention, Control Group, Physical activity tracker)
Not yet recruiting
- Obesity
- PATH Intervention
- +3 more
-
Atlanta, GeorgiaEmory University
Nov 7, 2023
Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- +3 more
- Retatrutide
- Placebo
-
Los Angeles, California
- +91 more
Jul 10, 2023
Obesity, Heart Failure With Preserved Ejection Fraction Trial in Worldwide (Tirzepatide, Placebo)
Recruiting
- Obesity
- Heart Failure With Preserved Ejection Fraction
- Tirzepatide
- Placebo
-
Huntsville, Alabama
- +144 more
Jan 18, 2023
Surgical Site Infection, Obesity, Diabetes Trial in United States (Negative Pressure Wound Therapy)
Completed
- Surgical Site Infection
- +3 more
- Negative Pressure Wound Therapy
-
Atlanta, Georgia
- +4 more
Nov 17, 2022
Obesity Trial in United States
Recruiting
- Obesity
-
Marina Del Rey, California
- +15 more
Oct 3, 2022
B-cell Acute Lymphoblastic Leukemia, Obesity Trial in United States (IDEAL2 Intervention)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Obesity
- IDEAL2 Intervention
-
Los Angeles, California
- +15 more
Jun 23, 2022
Colon Cancer, Obesity Trial in Atlanta (Experimental: High Fiber Diet (HFD), Healthy American Diet)
Recruiting
- Colon Cancer
- Obesity
- Experimental: High Fiber Diet (HFD)
- Healthy American Diet
-
Atlanta, GeorgiaRollins School of Public Health, Emory University
Jun 8, 2022
Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Type 2 Diabetes
- +2 more
- Tirzepatide
- Placebo
-
Birmingham, Alabama
- +74 more
Apr 18, 2022
Diabetes Type 2, Diabetes, Obesity Trial in Atlanta, Johns Creek (Cryoablation of the Vagus Nerve, Lifestyle Intervention)
Completed
- Diabetes Type 2
- +2 more
- Cryoablation of the Vagus Nerve
- Lifestyle Intervention
-
Atlanta, Georgia
- +4 more
Mar 25, 2022
Overweight, Obesity Trial in United States
Recruiting
- Overweight
- Obesity
-
Little Rock, Arkansas
- +27 more
Feb 11, 2022
Gastrectomy, Obesity Trial in Atlanta (ViSiGiĀ® 3D suction calibration device, Esophagogastroduodenoscopy (EGD) calibration)
Active, not recruiting
- Gastrectomy
- Obesity
- ViSiGiĀ® 3D suction calibration device
- Esophagogastroduodenoscopy (EGD) calibration
-
Atlanta, GeorgiaEmory University Hospital Midtown
Feb 9, 2022
Obesity, Overweight Trial in Worldwide (Semaglutide 1.0 mg, Semaglutide 2.4 mg, Placebo I (Semaglutide))
Completed
- Obesity
- Overweight
- Semaglutide 1.0 mg
- +3 more
-
Buena Park, California
- +146 more
Nov 8, 2021
Autism Spectrum Disorder, Obesity Trial in Atlanta (The Changing Health in Autism through Nutrition, Getting fit and Expanding
Completed
- Autism Spectrum Disorder
- Obesity
- The Changing Health in Autism through Nutrition, Getting fit and Expanding variety (CHANGE) Program
-
Atlanta, GeorgiaEmory University
Dec 2, 2020
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States
Unknown status
- Endometrial Clear Cell Adenocarcinoma
- +6 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +539 more
Mar 8, 2019
Metabolism and Nutrition Disorder, Obesity Trial in United States (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Anaheim, California
- +8 more
Mar 14, 2019
Obesity, Colorectal Carcinoma Trial in Atlanta (behavioral, device, other)
Completed
- Obesity
- Colorectal Carcinoma
- Legume diet group
- +3 more
-
Atlanta, Georgia
- +1 more
Jan 24, 2019
Obesity Trial in Atlanta, Johns Creek (Cryoablation)
Completed
- Obesity
- Cryoablation
-
Atlanta, Georgia
- +2 more
Oct 30, 2018
Obesity Trial in United States (S-2367 Placebo, S-2367 1600 mg q.d. 54 Weeks, S-2367 1600 mg q.d. 60 weeks)
Completed
- Obesity
- S-2367 Placebo
- +4 more
-
Birmingham, Alabama
- +39 more
May 9, 2018
Obesity Trial in United States (S-2367 Placebo, S-2367 800 mg, S-2367 1600 mg)
Completed
- Obesity
- S-2367 Placebo
- +3 more
-
Mobile, Alabama
- +37 more
May 8, 2018
Obesity Trial in United States (S-2367 (velneperit))
Completed
- Obesity
- S-2367 (velneperit)
-
Birmingham, Alabama
- +72 more
Apr 26, 2018
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Vestavia Hills, Alabama
- +160 more
Dec 6, 2017